Evidence map›Paper›PMID 37615049›Full record

ArticleAmerican journal of physiology. Renal physiology2023

Macrophage angiotensin AT

Naureen Fatima, Riyasat Ali, Tahmid Faisal, Kalyani Kulkarni, Sanket Patel, Tahir Hussain

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Rodent models of AKI and AKI-CKD transition: an update in 2024.American journal of physiology. Renal physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Naureen FatimaDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.ORCID 0000-0002-7839-8827
Riyasat AliDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.
Tahmid FaisalDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.ORCID 0000-0002-5523-407X
Kalyani KulkarniDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.
Sanket PatelDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.ORCID 0000-0003-1674-711X
Tahir HussainDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, United States.ORCID 0000-0002-6353-2317
University of Houston · US

Funding

Renal Angiotensin ll Receptor Function in ObesityR01DK061578 · NIDDK · UNIVERSITY OF HOUSTON · PI HUSSAIN, TAHIR · 2003 to 2020
$4.3M
Protective Arm of the Renin Angiotensin System in Obese KidneyR01DK117495 · NIDDK · UNIVERSITY OF HOUSTON · PI HUSSAIN, TAHIR · 2018 to 2021
$1.6M
NIDDK NIH HHS R01 DK061578NIDDK NIH HHS R01 DK117495
6 · The paper itself

Abstract

Lipopolysaccharide (LPS)-induced acute kidney injury (AKI) is characterized by inflammation and infiltration of immune cells, mainly neutrophils and macrophages, and results in sudden renal dysfunction. Previously, we have reported the anti-inflammatory and renoprotective role of the angiotensin II type 2 receptor (AT

Indexed as

Acute Kidney InjuryLipopolysaccharidesAngiotensinsAnimalsAnti-Inflammatory AgentsImidazolesMacrophagesMiceMice, Inbred C57BLReceptor, Angiotensin, Type 2SulfonamidesThiophenesAngiotensinsAnti-Inflammatory Agentscompound 21ImidazolesLipopolysaccharidesReceptor, Angiotensin, Type 2SulfonamidesThiophenesacute kidney injuryangiotensin II type 2 receptorcompound 21lipopolysaccharidemacrophage

Identifiers

PMID37615049
PMCPMC10878726
OpenAlexW4386117328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.